Your browser doesn't support javascript.
loading
Essential human resources for antimicrobial stewardship teams in Japan: Estimates from a nationwide survey conducted by the Japanese Society of Chemotherapy.
Maeda, Masayuki; Muraki, Yuichi; Kosaka, Tadashi; Yamada, Takehiro; Aoki, Yosuke; Kaku, Mitsuo; Seki, Masafumi; Tanabe, Yoshinari; Fujita, Naohisa; Niki, Yoshihito; Morita, Kunihiko; Yanagihara, Katsunori; Yoshida, Koichiro; Kawaguchi, Tatsuya.
  • Maeda M; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-4-5 Hatanodai, Shinagawa-ku, Tokyo, Japan. Electronic address: m-maeda@pharm.showa-u.ac.jp.
  • Muraki Y; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Kosaka T; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Pharmacy, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yamada T; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Pharmacy, Hokkaido University Hospital, Hokkaido, Japan.
  • Aoki Y; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan.
  • Kaku M; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Infection Control and Laboratory Diagnostics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Seki M; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, Miyagi, Japan.
  • Tanabe Y; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Internal Medicine, Niigata Prefectural Shibata Hospital, Niigata, Japan.
  • Fujita N; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Infection Control & Laboratory Medicine at University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Niki Y; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Clinical Infectious Diseases, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan.
  • Morita K; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyoto, Japan.
  • Yanagihara K; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Yoshida K; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Division of Infection Control and Prevention, Department of Medical Safety Management, Kindai University Hospital, Osaka, Japan.
  • Kawaguchi T; The Antimicrobial Stewardship Committee of Japanese Society of Chemotherapy, Japan; Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan.
J Infect Chemother ; 25(9): 653-656, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31182329
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Guideline Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Guideline Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article